Reardon Andrew sold LGND
February 14, 2026 · Form 4 insider transaction
Reardon Andrew sold 3,211 shares of Ligand Pharmaceuticals Incorporated at $183.83 per share, a transaction worth $590.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,211
Price
$183.83
Total value
$590.3K
InsiderReardon Andrew
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 14, 2026
Filing dateFebruary 18, 2026
Shares owned after34,528
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of PSUs.